Promoter holding
64.27%
ML
Msn Laboratories Private Limited - Due diligence report
A 360° intelligence report on Msn Laboratories: trust score, financial health, credit view, compliance, directors, growth and distress signa…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹349
50% off
New user
Or enjoy up to 50% off with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Msn Laboratories — 360° Intelligence Report
Generated from MCA filings & public records85/100
Trust Score
Low Risk
Msn Laboratories is assessed as Low Risk with a Trust Score of 85/100. Msn Laboratories is an active private limited indian non-government company incorporated in 2003, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.
Report generated on 29 Jun 2026 from the latest processed filings. Msn Laboratories Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
85/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
68/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
75/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Consolidated · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 75/100 Low Risk
- Open charges exceed net worth - secured lenders rank ahead.
- Moderate gearing (D/E 38%).
- Working-capital cover adequate.
- Profitable - internal accruals available.
- Externally credit-rated (A).
Charges position: 65 open (6,705.38 cr) · 19 satisfied (364.01 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Others | 18 | 48.0 cr |
| State Bank Of India | 4 | 48.0 cr |
| Hdfc Bank Limited | 6 | 48.0 cr |
| Axis Bank Limited | 46 | 48.0 cr |
| Canara Bank | 1 | 48.0 cr |
| Bank Of India | 1 | 48.0 cr |
Compliance Score: 68/100 Moderate
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2024).
- Litigation present in 3 court forum(s).
- 21 active GST registration(s).
Legal cases on record (3)
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SATYANARAYANA REDDY MANNE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SINDHUJA REDDY MANNE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| LAXMI PRASUNA MANNE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ACHYUTH REDDY MANNE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VINOD KUMAR CHAWLA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BHARAT REDDY CHINTAPALLY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 6 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2024 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
1
Group entities
1
Capital events
0 allotment(s) · 10 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Cramsn Research Park Private Limited | Subsidiary Company | 74.00% |
| Emesgen Pharmaceuticals Inc | Subsidiary Company | 74.00% |
| Msn Laboratories Europe Limited | Subsidiary Company | 74.00% |
| Msn Laboratories Fz-llc | Subsidiary Company | 74.00% |
| Msn Labs Americas Sas | Subsidiary Company | 74.00% |
| Msn Labs Brasil Ltda | Subsidiary Company | 74.00% |
| Msn Labs Canada Inc | Subsidiary Company | 74.00% |
| Msn Labs Chile Spa | Subsidiary Company | 74.00% |
| Msn Labs Dr Srl | Subsidiary Company | 74.00% |
| Msn Labs Ecuador Sa | Subsidiary Company | 74.00% |
Key managerial personnel: SATYANARAYANA REDDY MANNE (Managing Director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 95 · Distress 80
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Latest year revenue grew 2.1x.
Profit expanded 24% year-on-year.
Asset base grew 0.86 - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 22+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 61% in a year.
65 open charge(s) registered - assets are encumbered.
3 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence77/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment79/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 65 open charge(s) of 6,705.38 cr already registered.
- Compliance gaps should be priced into terms.
Investor view92/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 5 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events17 Nov 2025
Charge satisfied
Others
31 Oct 2025
Charge created
Axis Bank Limited - 30.00 Lakh
Charge created
Axis Bank Limited - 35.00 Lakh
30 Sep 2025
Charge created
Axis Bank Limited - 35.00 Lakh
26 Sep 2025
Charge created
Axis Bank Limited - 22.58 Lakh
02 Sep 2025
Charge created
Others - 2.09 Lakh
29 Aug 2025
Charge created
Axis Bank Limited - 35.00 Lakh
28 Aug 2025
Charge created
Others - 200.00 cr
30 Jul 2025
Charge created
Axis Bank Limited - 28.86 Lakh
27 Jun 2025
Director appointed
SINDHUJA REDDY MANNE (Director)
Director appointed
ACHYUTH REDDY MANNE (Director)
13 Jun 2025
Charge created
Axis Bank Limited - 22.90 Lakh
11 Jun 2025
Charge created
Axis Bank Limited - 25.00 Lakh
30 May 2025
Charge created
Others - 100.00 cr
30 Apr 2025
Charge created
Axis Bank Limited - 28.82 Lakh
10
Key Observations
Auto-generated from the data aboveRevenue grew 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Debt-to-equity stands at 24% - manageable leverage.
Net worth is positive.
6 active director(s) / partner(s); board looks stable and experienced.
21 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
Carries an external credit rating of A from Crisil.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
131 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Supreme Petrochem | L23200MH1989PLC054633 | Mumbai, Maharashtra, India |
| Thermax | L29299PN1980PLC022787 | Pune, Maharashtra, India |
| Ipca Laboratories | L24239MH1949PLC007837 | Mumbai, Maharashtra, India |
| Aarti Industries | L24110GJ1984PLC007301 | Vapi, Gujarat, India |
| Alkem Laboratories | L00305MH1973PLC174201 | Mumbai, Maharashtra, India |
| Seruminstitute | U80903PN1984PTC032945 | Pune, Maharashtra, India |
| Tergene Biotech | L24239TG1986PLC015190 | Hyderabad, Telangana, India |
| Haldiapetrochemicals | U24100WB2015PLC205383 | Kolkata, West Bengal, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Msn Laboratories before audits and certifications: compliance score 68/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Msn Laboratories: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 75/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Msn Laboratories - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 85/100, distress signals and MSME payment-delay disclosures - know whether Msn Laboratories pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Msn Laboratories - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Msn Laboratories an active company?
Msn Laboratories has MCA status “Active” with a compliance score of 68/100 (Moderate).
Is Msn Laboratories financially healthy?
Msn Laboratories has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.
Should I do business with Msn Laboratories?
Its overall Trust Score is 85/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Msn Laboratories?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 6 active director(s) are on record.
Does Msn Laboratories have loans or charges against its assets?
65 open charge(s) are registered against its assets, and 19 earlier charge(s) stand satisfied.
Is Msn Laboratories up to date with its ROC filings?
Balance sheet slightly behind (Mar 2024). Overall compliance score: 68/100 (Moderate).
Is it risky to lend to Msn Laboratories?
Its Credit Risk Score is 75/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
